Summary
CluePoints provides Sponsors and CROs a better way of detecting and managing risks that may impact the outcome of clinical trials. Our solutions, all of which are underpinned by Central Statistical Monitoring, a technique that’s being investigated by the FDA for selecting sites for inspection, are deployed to drive a Risk-Based Quality Management strategy, as advocated by ICH and FDA.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Francois Torche
Founder and CEO
Andy Cooper
CEO
Patrick Hughes
Co-Founder
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy